However, in human T1D and mouse models of insulin-dependent diabetes mellitus, the autoreactive CD4+ T cell response has been shown to target trans-spliced self-epitopes [(29–31), and reviewed in Ref. Here, CD4 is linked to type 1 diabetes mellitus.